Financial Year |
September 30 2019 |
Monetary Funds |
27,569,034.10 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
14,765,256.00 |
Accounts Receivable |
964,240,666.49 |
Advances to Suppliers |
610,333,820.51 |
Other Receivables |
458,481,482.26 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
325,908,175.67 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
53,373,080.19 |
Total Current Assets |
2,454,671,515.22 |
Available-for-Sale Financial Asset |
1,055,925.00 |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
114,402,302.89 |
Investment Properties |
-- |
Fixed Assetes |
1,151,414.06 |
Under-construction Projects |
305,181.20 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
3,005,756.06 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
-- |
Other Non-Current Assets |
86,207,718.66 |
Sub-Total of Non-Current Assets |
206,128,297.87 |
Total Assets |
2,660,799,813.09 |
Short-Term Loans |
74,827,700.00 |
Trading Financial liabilities |
-- |
Notes Payable |
25,172,300.00 |
Accounts Payable |
320,640,792.96 |
Accounts Received In Advance |
18,727,266.38 |
Employee Compensation Payable |
3,577,352.75 |
Taxes Payable |
829,483.10 |
Interest Payable |
79,221,020.49 |
Dividend Payable |
-- |
Other payables |
152,949,502.27 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
400,019,960.94 |
Sub-Total of Current Liabilities |
996,744,358.40 |
Long-term Loans |
-- |
Bonds Payable |
399,317,038.31 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
399,317,038.31 |
Total Liabilities |
1,396,061,396.71 |
Paid-In Capital(Or Share Stock) |
73,948,803.00 |
Capital Surplus |
-16,269,964.09 |
Surplus Reserve |
102,192,266.02 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
902,691,633.05 |
Minority Stockholder's Interest |
186,830,264.58 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,077,908,151.80 |
Owner's Equity(Stockholder's Equity) |
1,264,738,416.38 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,660,799,813.09 |